Level C· Early human research exploring benefitsProspective StudyPubMed

Composite Scaffolds of Decellularized Placenta/PRP Enhance the Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells Into Insulin-Producing Cells In Vitro.

Bozorgi A., Bozorgi M., Rezakhani L., Khazaei M.

Prospective Study on Systemic / IV, published in J Biomed Mater Res B Appl Biomater (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
J Biomed Mater Res B Appl Biomater (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
40923712
DOI
10.1002/jbm.b.35639

Abstract (original English)

In the current in vitro experiment, we fabricated and characterized placenta/platelet-rich plasma (PL/Pt) composite scaffolds and evaluated their effect on differentiating adipose stem cells (ASCs) into insulin-producing cells (IPCs) in vitro. The human placenta (PL) was decellularized (dPL), characterized, and digested in pepsin. PRP was extracted using a two-step centrifugation process and then freeze-dried. PL/Pt composite scaffolds were fabricated from PL with various PRP concentrations (1, 2.5, and 5 mg·mL) and characterized. ASCs were isolated from adipose tissue and characterized using flow cytometry and multilineage differentiation assays. ASCs were seeded onto PL/Pt scaffolds and differentiated into IPCs. The decellularized placenta retained its collagen content and had minimal cellular and DNA content. ASCs expressed CD73, CD90, and CD105 but not CD34 and CD45 and differentiated into osteoblasts and adipocytes. PL/Pt scaffolds showed appropriate morphological and chemical properties with improved porosity, swelling, and degradation rates. Seeding cells on the PL scaffolds increased PDX1, GLUT2, and insulin expression significantly compared to cells cultured in plates. Cells seeded on PL/Pt2.5 and PL/Pt5 scaffolds showed a remarkable increase in PDX1, GLUT2, and insulin expression. Additionally, differentiated cells cultivated on PL/Pt scaffolds exhibited enhanced insu

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansPlacentaCell DifferentiationFemalePregnancyTissue ScaffoldsMesenchymal Stem CellsAdipose TissuePlatelet-Rich PlasmaInsulin

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research